SPOTLIGHT -
Zelnorm Returns--Sort Of
Novartis' Zelnorm is back, but only through a restricted-access program.
Anti-Obesity Drugs Struggle In Growing Market
A new study says obesity is like a social virus, so why is the obesity-drug market just sitting there?
